Maharashtra FDA cancels Cipla warehouse licences in Pune's Wadki

Maharashtra's Food and Drug Administration (FDA) has cancelled the drug sale and distribution licences of Cipla's warehouse in Pune’s Wadki. The action followed proceedings over violations involving drug Reactin Plus Tablets, whose packaging carried unauthorised claims and illustrations. FDA also found deficiencies in storage, documentation and inventory management practices at the facility.